A biological explanation for depression: the role of interleukin-6 in the aetiology and pathogenesis of depression and disease and its clinical implications

Zhang, Stephy (2012) A biological explanation for depression: the role of interleukin-6 in the aetiology and pathogenesis of depression and disease and its clinical implications. Australian Medical Student Journal, 3 (2). pp. 24-26.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: http://www.amsj.org/archives/2448
 
1


Abstract

Depression is one of the most common health problems addressed by general practitioners in Australia. It is well known that biological, psychosocial and environmental factors play a role in the aetiology of depression. Research into the possible biological mechanisms of depression has identified interleukin-6 (IL-6) as a potential biological correlate of depressive behaviour, with proposed contributions to the aetiology and pathogenesis of depression. Interleukin-6 is a key proinflammatory cytokine involved in the acute phase of the immune response and a potent activator of the hypothalamic-pitutary-adrenal axis. Patients with depression have higher than average concentrations of IL-6 compared to non- depressed controls, and a dose-response correlation may exist between circulating IL-6 concentration and the degree of depressive symptoms. Based on these insights the 'cytokine theory of depression' proposes that proinflammatory cytokines, such as IL-6, act as neuromodulators and may mediate some of the behavioural and neurochemical features of depression. Longitudinal and case- control studies across a wide variety of patient cohorts, disease states and clinical settings provide evidence for a bidirectional relationship between IL-6 and depression. Thus IL-6 represents a potential biological intermediary and therapeutic target for the treatment of depression. Recognition of the strong biological contribution to the aetiology and pathogenesis of depression may help doctors to identify individuals at risk and implement appropriate measures, which could improve the patient’s quality of life and reduce disease burden.

Item ID: 25295
Item Type: Article (Other)
ISSN: 1837-1728
Additional Information:

Literature review

Date Deposited: 06 Mar 2013 01:46
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110319 Psychiatry (incl Psychotherapy) @ 100%
SEO Codes: 92 HEALTH > 9202 Health and Support Services > 920209 Mental Health Services @ 100%
Downloads: Total: 1
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page